Workshop Session 1 (Day 1)
View in AgendaCo-infections
Facilitator: James Platts-Mills
Presentations
- Diagnostics/attribution
- Clinical consequences of co-infections & implications for vaccine trial endpoints
Speakers
- What is a co-infection?, how common are they?
- Are they clinically relevant, and do some matter more than others?
- Do they need to be considered for vaccine trials?
Adenovirus
Facilitator: Firdausi Qadri
Presentations
- Burden of adenovirus-associated diarrheal hospitalizations in Indian children under 5 in the post rotavirus vaccine era
- Severity of adenovirus and potential role of sequential infections
- Role of non-enteric adenoviruses
- Adenovirus immunity and vaccine prospects
- How much does adenovirus contribute to diarrhea morbidity? Mortality?
- How important are non-enteric adenoviruses?
- What research is needed to better clarify the role/importance of adenovirus?
Special populations
Facilitator: Richard Omore
Presentations
- Diarrhea burden in older adults in Cameroon: A case control study using low cost specimen preservation
- Adult diarrhea – Peru
- HIV
- Can traveler-derived genomic data strengthen enteric surveillance in LMICs?
- How can we capture diarrhea burden and etiology in special populations?
- What is the evidence it is variable?
Workshop Session 2 (Day 2)
View in AgendaVaccines
Facilitator: Miren Iturriza
Presentations
- New vaccine timelines
- Oral vaccine performance for rotavirus and other enteric diseases
- Vaccines and indirect protection
- Vaccine impact on Antimicrobial usage – lessons learned from Typhoid conjugate vaccines
- What diarrhea surveillance do we need in place to support vaccines (pathogen prioritization, product development, testing, policy, post-introduction evaluation)?
- How long after a vaccine is introduced (e.g. rotavirus vaccine) should surveillance continue?
Nonclinical approaches to diarrhea surveillance
Facilitator: Supriya Kumar
Presentations
- WES in India
- Sewage surveillance for enteric diseases from Dhaka, Bangladesh study
- Lessons from Malawi: Can Environmental Surveillance Guide Shigella Vaccine Planning?
- Seroepidemiology for diarrheal pathogens
- What are the diarrheal pathogens for which WES and/or seroepidemiology has a strong use case?
- What are the limitations?
- For what purposes can the data be used?
Workshop Session 3 (Day 3)
View in AgendaDiagnostics
Facilitators: Keerthi Boddupally & Chitra Pattabiraman
Discussion on building sustainable diagnostic surveillance infrastructure.
Design
Facilitators: Thomas Cherian & Kirsten Vannice
Discussion on the future design of global pediatric diarrhoea surveillance.
Finance and operation
Facilitators: Arindam Ray & Sarang Deo
Discussion on the financial models and operational strategies for sustainable systems.